Access
This article is part of Nature's premium content.
Published online 26 September 2007 | Nature 449, 385 (2007) | doi:10.1038/449385a
News: Q&A
Q&A: King of the stem cells
On 14 September, the California Institute for Regenerative Medicine (CIRM) appointed Australian biologist Alan Trounson as its new president. The CIRM has lacked a permanent director since neuroscientist Zach Hall departed in April, amidst rumours of tension between himself and Robert Klein, chair of the $3-billion agency's board.
Why were you picked?
I think the CIRM board was interested in my perspective of wanting to push very hard at the pipeline between discovery and clinical application. I am more interested in getting discoveries through to the clinic than simply commercial operations or research for the sake of research.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
